These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2010-023895-26||Estudio de prueba de concepto diseñado para evaluar los efectos de Octreolin sobre el gradiente de presión venosa hepática en sujetos con cirrosis e hipertensión portal||not-yet-due|
|Listed as ongoing, but also has a completion date and reported results||2011-002912-10||Efficacy and safety of oral Octreolin™ in patients with acromegaly who are currently receiving parenteral somatostatin analogs||2014-12-05||bad-data|
|Reported results||2015-001292-51||Follow-Up Study in Patients with Acromegaly Previously Participating in Chiasma Study CH-ACM-01||2016-01-08||due-trials|
|Other||2015-002854-11||A phase 3, randomized, open-label, active controlled, multicenter study to evaluate maintenance of response, safety and patient reported outcomes in acromegaly patients treated with octreotide capsule...||not-yet-due|
|Ongoing||2017-000737-31||A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of octreotide capsules in patients who previously tolerated and demonstrated biochemical cont...||not-yet-due|